Company Overview of Capital International, Inc.
Capital International, Inc. is a privately owned investment manager. The firm primarily provides its services to individuals, corporate and public pension plans and profit sharing plans, pooled investment vehicles, foreign governmental entities, investment companies, corporations, state or municipal government entities, and institutions in Asia, Australia, and New Zealand. It manages client specific portfolios and investment funds for its clients. The firm invests in the public equity, fixed income, and private equity markets across the globe. Its equity investments includes of growth stocks. The firm’s fixed income investments include investment grade securities of governmental, supranation...
11100 Santa Monica Boulevard
Los Angeles, CA 90025-3384
Founded in 1987
Key Executives for Capital International, Inc.
Managing Partner and Member of Investment Committee
Compensation as of Fiscal Year 2014.
Capital International, Inc. Key Developments
Temasek, Capital International Eye Avantha's Consumer Buz Stake
Nov 27 14
Capital International Inc., Temasek Holdings (Private) Limited and Bain Capital, LLC are keen to acquire a minority stake in Crompton Greaves Consumer Products of Avantha Holdings Limited. Avantha Holdings would sell a part of its 42.7 per cent stake in Crompton Greaves Consumer Products. Avantha Holdings directly owns 40.84% stake with the rest held by other investment entities. Gautam Thapar of Avantha announced that it is planning to sell around 7% stake in Crompton Greaves. As the news came out Crompton Greaves fell as much as 5.5% on November 27, 2014.
Capital International, Inc. Presents at 16th Annual Global Private Equity Conference, May-13-2014 09:15 AM
Mar 21 14
Capital International, Inc. Presents at 16th Annual Global Private Equity Conference, May-13-2014 09:15 AM. Venue: Ritz-Carlton, Washington, District Of Columbia, United States. Speakers: Koenraad Carl Alice Foulon, Senior Vice President, Private Equity Senior Managing Partner, Director, and the Chairman of the Investment Committee.
Investors Reportedly Eyes Stake In Intas
Jan 29 14
Temasek Capital, GIC Pte. Ltd., and Capital International, Inc. are in independent talks to purchase ChrysCapital's 10% stake in Intas Pharmaceuticals Ltd. for about $150 million, three people with direct knowledge of the development said. An investment banker said, "Chrys-Capital is looking to sell part of its 16.5% stake after Intas Pharma postponed its initial public offering due to muted market conditions." "Yes, ChrysCapital is looking for partial exit from the company and the IPO plan was also formulated with the objective of providing exit," Jayesh Shah, Chief Financial Officer of Intas Pharma said in an email response. "However, Intas is still evaluating various options to provide meaningful exit to ChrysCapital and nothing has been concretised so far." Another person familiar with the matter said, "Along with the partial exit of the existing investor, the promoters could look at raising fresh funds for the company." "No valuation number has been frozen," said Shah of Intas.
Similar Private Companies By Industry
Recent Private Companies Transactions